Importantly, reversal of epigenetic reprogramming during disease progression with pharmacological inhibitors, such as histone deacetylase (HDAC) and DNA methyltransferase (DNMT) inhibitors, could overcome chemotherapy-resistance in tumour cells16–19. The gene discussed is HDAC9; the disease is neoplasm.